Concepedia

Edwin Chapman

EC

Statistics

Publications

4

Citations

95

H-Index

4

Active since

2017

Affiliations

Howard University(Current)

Eötvös Loránd University

Wright State University

University of Vermont

Institute of Bioinformatics and Applied Biotechnology

Edwin Chapman is an author at Howard University specializing in opioid pharmacogenetics, pharmacology, and substance use disorders.

Publications per year

2017–2022

4

Publications

4

The Benefits of Genetic Addiction Risk Score (GARS<sup>™</sup>) Testing in Substance Use Disorder (SUD).

Kenneth Blum, Edward J. Modestino, Marjorie C. Gondré‐Lewis et al. · PubMed · 2018 · 28 citations

Life Sciences, Genetics, Psychiatry +17

Pharmacogenomics and Opioid Use Disorder: Clinical Decision Support in an African American Cohort

Earl Ettienne, Adaku Ofoegbu, Mary Maneno et al. · Journal of the National Medical Association · 2019 · 26 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach

Earl Ettienne, Edwin Chapman, Mary Maneno et al. · Addictive Behaviors Reports · 2017 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

Marjorie C. Gondré‐Lewis, Igor Elman, Tanya N. Alim et al. · Biomedicines · 2022 · 19 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–4 of 4